|Articles|February 4, 2009
Avastin for myopic CNV
Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularisation: 1-year results of a prospective pilot study
Advertisement
Please click
Newsletter
Advertisement
Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularisation: 1-year results of a prospective pilot study
Please click